Archives

  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • 2025-05
  • 2025-04
  • ML324

    2025-09-17

    ML324

    Author: ApexBio

    spu:

    B4891

    CAS:

    1222800-79-4

    purity:

    0.9828

    shortsummary:

    JMJD2 demethylase inhibitor, potent and cell-permeable

    venetoclax manufacturer

    Formula:

    C21H23N3O2

    M.Wt:

    349.43

    Chemical Name:

    N-(3-(dimethylamino)propyl)-4-(8-hydroxyquinolin-6-yl)benzamide

    SMILES:

    CN(CCCNC(C1=CC=C(C2=CC(O)=C3C(C=CC=N3)=C2)C=C1)=O)C

    Solubility:

    insoluble in H2O; ≥17.45 mg/mL in DMSO; ≥2.4 mg/mL in EtOH with ultrasonic

    Storage:

    Store at -20°C

    Physical Appearance:

    A solid

    DeliveryTime:

    Ship with 10-15 days

    buy MOG (35-55)

    ShippingType:

    Blue ice

    description:

    ML324 is a potent and cell-permeable JMJD2 demethylase inhibitor (IC50 = 920 nM). [1]
    Jumonji-domain-containing proteins (JMJD) is the largest class of N ε -methyl lysine demethylase, an enzyme that demethylates the tri-methylated H3K9. JMJD takes part in gene transcription regulation. [1]
    ML324 acted as an antiviral agent that effectively inhibited HSV and hCMV IE gene expression in HFF and MRC-5 cells, resulted in suppression of HSV plaques formation and inhibition of HSV infection spread. [1]
    ML324 also blocked HSV-1 reactivation and inhibited the formation of HSV plaque in mouse ganglia explant model of latently infected mice. [1]
    References:
    1.Rai G, Kawamura A, Tumber A, Liang Y, Vogel JL, Arbuckle JH, Rose NR,
    Dexheimer TS, Foley TL, King ON, Quinn A, Mott BT, Schofield CJ, Oppermann U,Jadhav A, Simeonov A, Kristie TM, Maloney DJ. Discovery of ML324, a JMJD2
    demethylase inhibitor with demonstrated antiviral activity. 2012 Dec 17 [updated 2013 Sep 16]. Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.

    ML324 PMC11277400

    related websites:

    APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 4448 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.

    https://www.apexbt.com/